Oculis Holding AG (OCS) Times Interest Earned (2022 - 2026)
Oculis Holding AG (OCS) posted quarterly Times Interest Earned of $658.42 for Q1 2026, down 60.44% year-over-year from $1664.5 in Q1 2025, and up 14.88% quarter-over-quarter from $573.14 in Q4 2025.
Powered by 
Analysis
Oculis Holding AG (OCS) Times Interest Earned (2022 - 2026) Analysis & Trends
Oculis Holding AG's Times Interest Earned history runs 5 years deep, the most recent figure standing at $658.42 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 60.44% year-over-year to $658.42; the TTM figure through Mar 2026 stood at $168.31 (up 112.19% YoY), while the FY2025 annual figure was -$98.05, up 14.42% from the prior year.
- Times Interest Earned for Q1 2026 stood at $658.42, up from $573.14 in the prior quarter.
- The five-year high for Times Interest Earned was $1664.5 in Q1 2025, with the low at -$632.06 in Q2 2023.
- The 5-year median for Times Interest Earned is $0.55 (2025), against an average of $336.54.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned slumped 11491.84% in 2023, then soared 4429.21% in 2024.
- Oculis Holding AG's Times Interest Earned stood at -$8.5 in 2022, then slumped by 7333.64% to -$632.06 in 2023, then jumped by 310.06% to $1327.7 in 2024, then sank by 56.83% to $573.14 in 2025, then advanced by 14.88% to $658.42 in 2026.
- Business Quant data shows OCS's Times Interest Earned at $658.42 in Q1 2026, $573.14 in Q4 2025, and $0.04 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Oculis Holding AG | 634.75 Mn | 345.87 Mn | - | -1.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 |
| Mar 31, 2026 | -1.21 |
| Dec 31, 2025 | -1.71 |
| Sep 30, 2025 | -1.50 |
| Jun 30, 2025 | -1.43 |
| Mar 31, 2025 | -1.15 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -0.82 |
| Jun 30, 2024 | -2.82 |
| Mar 31, 2024 | -5.41 |
| Dec 31, 2023 | -15.42 |
| Sep 30, 2023 | -19.91 |
| Jun 30, 2023 | -14.71 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.15 |